Expression of P-glycoprotein influences resistance against anthracyclines in clinical gastric carcinomas
- 1 March 1994
- journal article
- Published by Wiley in Seminars in Surgical Oncology
- Vol. 10 (2), 135-139
- https://doi.org/10.1002/ssu.2980100215
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Reversal of Drug Resistance in a Human Colon Cancer Xenograft Expressing MDR1 Complementary DNA by In Vivo Administration of MRK-16 Monoclonal AntibodyJNCI Journal of the National Cancer Institute, 1991
- Clinical Relevance of Immunohistochemical Detection of Multidrug Resistance P-Glycoprotein in Breast CarcinomaJNCI Journal of the National Cancer Institute, 1991
- Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancerHuman Pathology, 1990
- Chemosensitivity Patterns and Expression of Human Multidrug Resistance-Associated MDR1 Gene by Human Gastric and Colorectal Carcinoma Cell LinesJNCI Journal of the National Cancer Institute, 1990
- Expression of a Multidrug Resistance Gene in Esophageal Adenocarcinoma: Correlation with Response to Chemotherapy and Comparison with Gastric AdenocarcinomaAmerican Journal of Clinical Pathology, 1990
- Modulation by verapamil of vincristine pharmacokinetics and toxicity in mice bearing human tumor xenograftsBiochemical Pharmacology, 1989
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987
- Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine.Proceedings of the National Academy of Sciences, 1987
- Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodiesNature, 1985
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981